News

TheProstate Cancer Charity has welcomed the National Institute for Health and Clinical Excellence's (NICE) draft decision to recommend that denosumab be made available for men with advanced prostate cancer which has spread to the bone on the NHS throughout the UK.

New research - funded by The Prostate Cancer Charityand undertaken by the University of Stirling's Cancer Care Research Centre - has revealed that men have a worrying tendency to delay before going to a GP to discuss symptoms which may be an indication of prostate cancer.